MedPath
TGA Approval

DEXEMCIP dexmedetomidine (as hydrochloride) 200 microgram/2 mL concentrated injection vial (321728)

321728

DEXEMCIP dexmedetomidine (as hydrochloride) 200 microgram/2 mL concentrated injection vial

Cipla Australia Pty Ltd

June 16, 2020

Medicine

Medicine

Active

Registered

Active Ingredients

dexmedetomidine hydrochloride

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.